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CitS of Klebsiella pneumoniae is a secondary trans-
porter that transports citrate in symport with 2 Na
ions. Reaction of Cys-398 and Cys-414, which are located
in a cytoplasmic loop of the protein that is believed to be
involved in catalysis, with thiol reagents resulted in
significant inhibition of uptake activity. The reactivity
of the two residues was determined in single Cys mu-
tants in different catalytic states of the transporter and
from both sides of the membrane. The single Cys mu-
tants were shown to have the same transport stoichiom-
etry as wild type CitS, but the C398S mutation was re-
sponsible for a 10-fold loss of affinity for Na. Both
cysteine residues were accessible from the periplasmic
as well as from the cytoplasmic side of the membrane by
the membrane-impermeable thiol reagent [2-(trimethyl-
ammonium)ethyl] methanethiosulfonate bromide (MT-
SET) suggesting that the residues are part of the trans-
location site. Binding of citrate to the outward facing
binding site of the transporter resulted in partial pro-
tection against inactivation by N-ethylmaleimide,
whereas binding to the inward facing binding site re-
sulted in essentially complete protection. A 10-fold
higher concentration of citrate was required at the cy-
toplasmic rather than at the periplasmic side of the
membrane to promote protection. Only marginal effects
of citrate binding were seen on reactivity with MTSET.
Binding of Na at the periplasmic side of the transporter
protected both Cys-398 and Cys-414 against reaction
with the thiol reagents, whereas binding at the cytoplas-
mic side was less effective and discriminated between
Cys-398 and Cys-414. A model is presented in which part
of the cytoplasmic loop containing Cys-398 and Cys-414
folds back into the translocation pore as a pore-loop
structure. The loop protrudes into the pore beyond the
citrate-binding site that is situated at the membrane-
cytoplasm interface.
The secondary citrate transporter CitS of Klebsiella pneu-
moniae is a member of the bacterial 2-hydroxycarboxylate
transporter (2HCT)1 family. Members of the 2HCT family
transport substrates that contain the 2-hydroxycarboxylate
motif, as in citrate, malate, lactate, etc. (1). The family contains
H and Na symporters that couple the translocation of the
substrate to the co-ion as well as precursor/product exchangers
that couple the uptake of the substrate to the excretion of a
metabolic end product (2, 3). CitS is a Na symporter. It oblig-
atorily couples the translocation of the divalent citrate anion
(Hcit2) to the translocation of two sodium ions and one proton
(4, 5). The CitS protein is an integral membrane protein con-
taining 446 amino acid residues (47.5 kDa). The protein is
believed to consist of a bundle of 11 hydrophobic transmem-
brane segments (TMSs) with the N and C terminus located in
the cytoplasm and periplasm, respectively (Fig. 1) (6–9). An
additional hydrophobic segment, predicted to be transmem-
brane as well, was shown to reside in the periplasm between
TMSs V and VI. The segment, termed Vb, and a stretch of
about 40 residues in the C-terminal part of the protein (region
Xa) are the two most conserved regions in the 2HCT family.
Evidence is accumulating that region Xa is part of the trans-
location site in the protein. Conserved residue Arg-428 in TMS
XI situated close to the membrane/cytoplasm interface is be-
lieved to bind one of the carboxylate groups of the substrate
(10, 11).
Recent crystal structures of the LacY and GlpT proteins,
both secondary transporters from the major facilitator super-
family, support the alternating access model for the transloca-
tion mechanism of secondary transporters (12, 13). In this
model, the proteins contain single binding sites for substrate
and co-ions that alternately are exposed to the two sides of the
membrane during the catalytic cycle. Coupling between the
co-ion and substrate fluxes is warranted by the condition that
only the transporters with the free and with the fully occupied
binding sites (“unloaded” and “fully loaded” states, respec-
tively) can reorient the binding sites, whereas the conforma-
tional change is blocked when co-ion or substrate is bound. An
important consequence of the alternating access model is that
residues, which are part of the translocation site and which in
topology models of the transporter reside in the membrane, are
in contact with the water phase. In a number of recent studies
this property was explored to identify (part of) the transloca-
tion site by identifying residues in transmembrane segments
that were accessible to small water-soluble methanethiosulfon-
ate (MTS) derivatives by using cysteine-scanning mutagenesis
(14–16). A related consequence is that certain of these residues
are expected to be accessible from both sides of the membrane
when the protein can freely reorient the binding sites. Surpris-
ingly, in a number of cases, this was observed for residues in
loop regions, rather than TMSs, which let to the suggestion of
pore-loop structures or re-entrant loops in secondary transport-
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ers (17–22). Pore-loop structures are loop regions that fold back
between the TMSs and are commonly observed in channel
proteins where they function as selectivity filters (23, 24). Well
studied examples are the bacterial and neuronal glutamate
transporters, GltT and GLT-1, in which pore-loops were shown
to play an important role in the translocation event (17, 18, 25,
26). Pore-loop structures are not observed in the LacY and
GlpT structures, and it is unknown whether or not they repre-
sent a different translocation mechanism.
The CitS protein contains five cysteine residues, all located
in the C-terminal part of the transporter. Cys-398 and Cys-414
are found in region Xa in the cytoplasmic loop between TMS X
and TMS XI (Fig. 1). Recently, we showed that alkylation of the
two cysteine residues by N-ethylmaleimide (NEM) resulted in
loss of activity, in line with the importance of region Xa in
catalysis (27). Most importantly, inactivation was also ob-
served with the membrane-impermeable thiol reagent [2-
(trimethylammonium)ethyl]methanethiosulfonate (MTSET)
added at the periplasmic side of the membrane revealing an
access pathway for the reagent between the periplasm and the
residues, possibly by formation of a pore-loop structure by the
cytoplasmic loop. The access pathway was blocked in the pres-
ence of the co-ion Na indicating that the region is sensitive to
translocation-linked conformational changes of the trans-
porter. Here we study in detail the accessibility of Cys-398 and
Cys-414 in single cysteine mutants of CitS in different catalytic
states of the transporter. We probed the two cysteine residues
by different sulfhydryl reagents and from both sides of the
membrane. The catalytic state of the transporter was modu-
lated through the presence and absence of citrate, Na, or both.
It follows that both positions are accessible from either side of
the membrane and that the accessibility is different in the two
orientations of the transporter. The results are consistent with
a pore-loop structure formed by part of region Xa.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Growth Conditions, and CitS Constructs—Esche-
richia coli strains DH5 and ECOMUT2 (28) were routinely grown in
Luria Bertani broth (LB) medium at 37 °C under continuous shaking at
150 rpm. When appropriate, the antibiotics ampicillin and chloram-
phenicol were added at a final concentration of 50 and 30 g/ml, re-
spectively. All genetic manipulations were done in E. coli DH5
whereas the CitS protein was expressed in E. coli ECOMUT2 harboring
plasmid pBADCitS and derivatives. Plasmid pBADCitS is based on
vector pBAD24 (Invitrogen) and codes for the wild type CitS protein
with an N-terminal His tag. Expression of the gene is under control of
the arabinose promoter (27). Expression of CitS was induced by adding
0.1% arabinose when the absorbance of the culture measured at 660 nm
(A660) reached a value of 0.6.
Cysteine mutants of CitS were constructed by PCR using the Quick-
ChangeTM Site-directed Mutagenesis kit (Stratagene, La Jolla, CA).
Plasmid pHisCitS is based on the pBluescript vector (Stratagene) and
was used as the template (7). All mutants were sequenced (Baseclear,
Leiden, The Netherlands) to confirm the presence of the desired muta-
tions and cloned into the pBAD24 vector as described before (27).
Preparation of Right Side Out and Inside Out Membrane Vesicles—
E. coli ECOMUT2-expressing CitS variants were harvested from a
1-liter culture by centrifugation at 10,000  g for 10 min at 4 °C. Right
side out (RSO) membrane vesicles were prepared by the osmotic lysis
procedure as described (29).
Inside out (ISO) membranes were prepared by washing the cells once
with 10 mM Tris-HCl buffer, pH 8, followed by resuspending in 10 ml of
50 mM KPi buffer, pH 7, containing 2 mM MgSO4 and 10 g/ml deoxyri-
bonuclease. The suspension was passed once through a French press
cell operated at 13,000 pounds/square inch. Cell debris and unbroken
cells were removed by centrifugation at 8000 rpm for 10 min at 4 °C in
a Beckman SS34 rotor. Membranes were collected by ultracentrifuga-
tion for 25 min at 80,000 rpm at 4 °C in a Beckman TLA 100.4 rotor and
washed once with 50 mM KPi, pH 7.
RSO and ISO membranes were resuspended in low Na 50 mM KPi,
pH 7.0, rapidly frozen, and stored in liquid nitrogen. Membrane protein
concentration was determined by the DC Protein Assay Kit (Bio-Rad).
Partial Purification of CitS Using Nickel-Nitrilotriacetic Acid Affin-
ity Chromatography—ISO membranes (4 mg/ml) containing His-tagged
CitS derivatives were solubilized in 50 mM KPi, pH 8, 400 mM NaCl,
20% glycerol, and 1% Triton X-100. The solution was left on ice for 30
min. Undissolved material was removed by ultracentrifugation at
80,000 rpm for 25 min at 4 °C. The supernatant was mixed with Ni2-
nitrilotriacetic acid resin (100-l bed volume per 10 mg of protein),
equilibrated in 50 mM potassium phosphate pH 8.0, 600 mM KCl, 10%
glycerol, 0.1% Triton X-100, 10 mM imidazole and incubated for 1 h at
4 °C under continuous shaking. After incubation, the resin was pelleted
down by pulse centrifugation, and the supernatant was removed. The
pellet was washed with 10 volumes of equilibration buffer containing
300 mM KCl and 40 mM imidazole. The protein was eluted with 1 bed
volume of the same washing buffer but containing 50 mM potassium
phosphate, pH 7.0, and 150 mM imidazole and stored at 20 °C.
Transport Assay in RSO Membranes—Uptake was measured by the
rapid filtration method. RSO membranes were energized using the
potassium ascorbate/phenazine methosulfate (PMS) electron donor sys-
tem (30). Membranes were diluted to a final concentration of 0.5 mg/ml
into 50 mM KPi, pH 6.0, containing 70 mM Na
 unless stated otherwise,
in a total volume of 100 l at 30 °C. Under a constant flow of water-
saturated air, and while stirring magnetically, 10 mM potassium ascor-
bate and 100 M PMS (final concentration) were added, and the proton
motive force was allowed to develop for 2 min. Then, [1,5-14C]citrate
(114 mCi/mmol Amersham Biosciences) was added to a final concentra-
tion of 4.4 M. The uptake was stopped by the addition of 2 ml of ice-cold
0.1 M LiCl, followed by immediate filtration over cellulose nitrate filters
(0.45 m, pore size). The filters were washed once with 2 ml of the 0.1
M LiCl solution and assayed for radioactivity. The background was
estimated by adding the radiolabeled substrate to the vesicle suspen-
sion after the addition of 2 ml of ice-cold LiCl, immediately followed by
filtering. When indicated, experiments were carried out in low Na KPi
buffer that contains at most 0.005% of Na, whereas standard KPi
buffers may contain up to 0.3%.
Treatment of RSO and ISO Membranes with Thiol Reagents—Stock
solutions of NEM, MTSET, and AmdiS were prepared freshly in water.
RSO membranes at a concentration of 1 mg/ml and ISO membranes at
a concentration of 2 mg/ml were treated with the thiol reagents in 50
mM KPi, pH 7.0, at 20 °C. The treatment was stopped by addition of an
equal concentration of DTT in case of NEM and AmdiS or reduced
glutathione (GSH) in case of MTSET. The effect of Na on the treat-
ment was measured by adding mixtures of NaCl and KCl yielding the
same concentration of chloride. The effect of citrate on the treatment
was measured by adding citrate from a 0.5 M stock solution adjusted to
pH 6.0.
After the treatment, RSO membranes were diluted twice into 50 mM
KPi, pH 5.0. If necessary, NaCl and KCl were added to make the Na

concentrations 70 mM. The resulting suspension was pH 6 and was
immediately used to measure uptake activity. The presence of DTT or
GSH did not affect the uptake rate in the control experiments. Follow-
ing the treatment in the presence of citrate, the membranes were
washed twice with 50 mM KPi, pH 6.0, by centrifugation for 20 min in
a Beckman OptimaTM TLX ultracentrifuge in a TLA100.2 rotor to
remove citrate. Membranes were resuspended in 50 mM KPi, pH 6.0,
containing 70 mM Na and assayed for uptake activity. Control exper-
FIG. 1. Membrane topology model of CitS. Boxes represent puta-
tive transmembrane segments. The length of the loops correlates more
or less with the number of residues in the loops. Segment Vb corre-
sponds to a hydrophobic region that was predicted to be transmem-
brane. Loop Xa is one of the best conserved regions in the 2HCT family.
Numbers indicate the positions of the five endogenous cysteine resi-
dues. Arg-428 (R428) in TMS XI is involved in substrate binding.
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iment showed that the washing procedure resulted in a loss of 10–15%
of the uptake activity.
After the treatment of ISO membranes, CitS derivatives were par-
tially purified using nickel-nitrilotriacetic acid affinity chromatography
as described above and, subsequently, labeled with 0.1 mM fluorescein
5-maleimide (FM) in elution buffer for 5 min at room temperature. The
reaction was quenched with 0.5 mM DTT, and after addition of SDS
sample buffer, 25-l samples were run on a 12% SDS-PAGE gel. Fluo-
rescence of proteins labeled with FM was visualized on a Lumi-Imager
F1 imager (Roche Diagnostics) by irradiation with UV light using a
520-nm filter. All samples containing FM were kept out of bright light
until the gel was exposed. After exposure, the gel was stained with
Coomassie Brilliant Blue to compare the protein levels of CitS. Quan-
tification was done using the LumiAnalyst 3.1 software package sup-
plied by Roche Diagnostics.
Materials—2-(Trimethylammonium) ethyl methanethiosulfonate
bromide (MTSET) was purchased from Anatrace Inc. (Ohio). NEM was
purchased from Sigma, and AMdiS and FM were purchased from Mo-
lecular Probes Europe BV (Leiden, The Netherlands). Low Na potas-
sium buffer (KH2PO4) was purchased from Merck.
RESULTS
Activity of Single Cysteine Mutants SSSCS and SSSSC—
Wild type CitS transports citrate obligatorily coupled to the
translocation of two Na ions (4). The rate of uptake in RSO
membranes prepared from E. coli cells expressing CitS and
energized by the artificial electron donor system ascorbate/
PMS increased sigmoidally with increasing Na concentration.
Half of the maximal rate was obtained at a Na concentration
of 3 mM (27) (Fig. 2, ). The shape of the curve was not
significantly different for a mutant of CitS in which three out of
the five endogenous cysteine residues were replaced by serines
(mutant SSSCC, E). In addition, removing Cys-414, located in
the C-terminal loop of CitS (see Fig. 1), resulted in a slightly
lower affinity for Na (mutant SSSCS, ) without affecting the
shape of the curve (Fig. 2, inset). Half of the maximal rate was
obtained at a concentration of 6 mM Na. The low residual
uptake rate observed in the absence of added Na (about 2% of
the saturated rate; Fig. 2, inset) is due to low Na ion contam-
inations of the buffer system. A more drastic change in affinity
was observed when in addition to the three N-terminal cysteine
residues, Cys-398 was replaced by serine (mutant SSSSC, Fig.
2, ƒ). The apparent affinity for Na dropped to 28 mM, and
again, the sigmoidal increase of the rate with the Na concen-
tration was retained. A similar reduction in affinity for Na
was observed for the Cys-less mutant (SSSSS, Fig. 2, f) sug-
gesting that the C398S mutation in the SSSSC and SSSSS
mutants was responsible for the observed effect. The small
difference in affinity between the SSSSC and SSSSS mutants
is consistent with the observed difference between the SSSCC
and SSSCS mutants and suggests that the C414S mutation
lowers the affinity for Na independently of the effect of the
C398S mutation.
Finally, in the single cysteine mutants SSSCS and SSSSC,
the mechanism of citrate translocation is the same as observed
for wild type CitS. Uptake is strictly coupled to the uptake of
Na, and two Na are required for one translocation cycle.
Accessibility of Cys-398 and Cys-414 in the Unloaded State of
the Transporter—Treatment of RSO membrane vesicles con-
taining CitS mutant SSSCS with the membrane-permeable
maleimide NEM at a concentration of 2 mM for increasing
periods of time resulted in inhibition of the initial rate of citrate
uptake down to a residual activity of about 10% (Fig. 3A, ).
The half-time of inactivation was 8 min. Treatment of the same
membranes with the membrane-impermeable and more bulky
maleimide 4-acetamido-4-maleimidylstilbene-2,2-disulfonic
acid (AmdiS) did not result in significant inactivation under the
same conditions (Fig. 3A, E). In contrast, the membrane-im-
permeable but much smaller methanethiosulfonate MTSET
was very efficient in inactivating the SSSCS mutant. At the
same concentration, the half-time of inactivation was about 10
times shorter for MTSET than observed for NEM (Fig. 3A, ).
FIG. 2. The initial rate of citrate up-
take as a function of the Na concen-
tration in RSO membranes contain-
ing wild type CitS (CCCCC, ) and
the CitS cysteine mutants, SSSCC
(E), SSSCS (), SSSSC (ƒ), and SSSSS
(f). The rate was plotted as the fraction
of the rate measured at saturated Na
concentrations of 4.2 (CCCCC), 1.5
(SSSCC), 3.2 (SSSCS), 2.4 (SSSSC), and
2.0 (SSSSS) nmol/min per mg of protein.
Inset, initial rate of uptake catalyzed by
wild type CitS (CCCCC, ) and the
SSSCS mutant () in the concentration
range up to 1 mM Na.
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It should be noted that the reagents only had a marginal effect
on the uptake activity of RSO membrane vesicles containing
the Cys-less CitS mutant SSSSS (Fig. 3C). Qualitatively, the
results were the same for the reactivity of Cys-414 in mutant
SSSSC (Fig. 3B). Both NEM and MTSET inactivated the trans-
porter, whereas AmdiS did not. Quantitatively, the rates of
inactivation were much faster than observed for the SSSCS
mutant, with half-times below 20 s at concentrations of the
thiol reagents that were lower than used to inactivate SSSCS.
Both mutants showed a residual activity between 10 and 20%
after reaction with NEM and MTSET. It follows that Cys-398
and Cys-414 are both accessible to NEM and MTSET added at
the periplasmic side of the membrane. The different rates of
reaction may reflect differences in accessibility, different reac-
tivities of the two thiols, or both.
Membrane vesicles with an inverted orientation (inside out,
ISO) were used to determine the accessibility of Cys-398 and
Cys-414 with thiol reagents NEM, AmdiS, and MTSET from
the cytoplasmic side of the membrane. Mutants SSSCS and
SSSSC purified from ISO membranes in detergent solution
were visualized by labeling of the single cysteine residues with
the fluorescent maleimide FM, followed by SDS-PAGE and
fluorescence imaging of the gel (Fig. 4, A and B, lanes 1). No
fluorescent protein band was observed for the Cys-less CitS
(SSSSS; Fig. 4C). Pretreatment of purified SSSCS and SSSSC
with NEM (Fig. 4, A and B, lanes 3), AmdiS (lanes 5), and
MTSET (lanes 7) prevented subsequent labeling with FM,
showing that all molecules were accessible to the reagents in
the solubilized state.
Treatment of ISO membranes containing the SSSCS or
SSSSC mutants before purification with 2 mM NEM for 20 min
(SSSCS) or 0.5 mM NEM for 5 min (SSSSC) under the same
conditions as the RSO membranes above resulted in a 90%
decrease of the labeling with FM after purification of the pro-
teins (Fig. 4, A and B, lanes 2). As expected, membrane-perme-
able NEM was equally capable of reacting with both cysteine
residues in RSO and ISO membranes. Remarkably, treatment
of the membranes with 0.25 mM AmdiS for 20 (SSSCS) or 5 min
(SSSSC) significantly reduced labeling with FM indicating
that, in contrast to RSO membranes, in ISO membranes Cys-
398 and Cys-414 are accessible to AmdiS (Fig. 4, A and B, lanes
4). Treatment of the ISO membranes containing SSSCS and
SSSSC with MTSET at a concentration and for a time that
resulted in 90% inhibition in RSO vesicles almost completely
blocked further labeling with FM (Fig. 4, A and B, lanes 6),
showing that MTSET accesses the cysteine residues in both
RSO and ISO membranes.
In conclusion, in the unloaded state of the transporter, i.e. in
the absence of citrate and Na, both cysteine residues in region
Xa of CitS are accessible from the periplasmic as well as the
cytoplasmic side of the membrane for membrane-permeable
NEM and membrane-impermeable MTSET. Access for the
more bulky, impermeable AmdiS is restricted from the
periplasmic side but not from the cytoplasmic side.
FIG. 3. Residual activity of citrate uptake after treatment of RSO membranes containing the SSSCS (A), SSSSC (B), and SSSSS (C)
mutant with NEM (), AmdiS (E), and MTSET (). RSO membranes were incubated for the indicated time with 0.25 mM AmdiS (SSSCS,
SSSSSC, SSSSS), 2 mM MTSET (SSSCS, SSSSS), 0.5 mM MTSET (SSSSC), 2 mM NEM (SSSCS), 1 mM NEM (SSSSS), and 0.2 mM NEM (SSSSC).
Initial rates were expressed as the percentage of the initial rate catalyzed by untreated membranes.
FIG. 4. Labeling of the SSSCS (A), SSSSC (B), and the SSSSS
(C) mutants with FM. ISO membranes were not further treated (lanes
1) or pretreated with NEM (lanes 2 and 3), AmdiS (lanes 4 and 5), and
MTSET (lanes 6 and 7) in the presence (s) or absence (m) of 1% of the
detergent Triton X-100. The conditions of the pretreatment with the
thiol reagents were 2 mM NEM, 0.25 mM AmdiS, and 2 mM MTSET for
20 min (A), and 0.5 mM NEM, 0.25 mM AmdiS, and 0.5 mM MTSET for
5 min (B). After the treatment, the mutants were purified and treated
with 0.1 mM FM for 5 min. The top rows (FM) show the fluorescence
image of the gel, and the bottom rows show the gel after Coomassie
Brilliant Blue (CBB) staining. Shown on the left is the 37-kDa marker.
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Accessibility of Cys-398 and Cys-414 in the Citrate-bound State
of the Transporter—In RSO membranes, containing the SSSCS
mutant the presence of citrate resulted in partial protection of
CitS against NEM inactivation (Fig. 5A). The membranes were
treated with 2 mM of NEM for 20 min, which just about resulted
in maximal inactivation in the absence of citrate (see Fig. 3A).
Under these conditions, the residual activity increased from 14%
in the absence of citrate to 38% at 50 mM citrate. The lack of
change in residual activity above citrate concentrations of 10 mM
indicated that the thiol did react with NEM in the citrate-bound
state but at a slower rate than in the free state. A concentration
of citrate below 1 mM was enough to give half of the maximal
difference in residual activity. The experiment shows that CitS
binds citrate and that Cys-398 is accessible to NEM both in the
free and in the citrate-bound state.
In ISO membranes, using the same concentration of NEM for
the same amount of time, the presence of up to 5 mM citrate had
little effect on the labeling by NEM (Fig. 6A, lanes 2, 5, and 6).
However, at 50 mM citrate significant inhibition of NEM label-
ing was observed. Quantification of the fluorescence intensity
showed that the residual free thiols after NEM treatment at 50
mM citrate amounted up to 80% and that the concentration to
obtain half of the maximal protection was between 5 and 50 mM
(Fig. 5B), which is at least 10 times higher than observed for
the RSO membranes. The latter is explained by a higher reac-
tivity of the thiol or a lower affinity for citrate at the cytoplas-
mic side of the membrane as compared with the periplasmic
side. At any rate, citrate protects Cys-398 more efficiently in
the inward facing than in the outward facing binding site.
The presence of citrate had small but significant effects on
the reaction of Cys-398 with membrane-impermeable MTSET.
In RSO membranes, the residual activity after treatment with
2 mM MTSET for 5 min increased from 21 to 36% when 50 mM
citrate was present during the treatment (Table I). After the
same treatment of ISO membranes in the presence of increas-
ing concentrations of citrate, the percentage of free thiols
changed from 13 to 28% (Fig. 6A, lanes 2, 5, and 7; Table I).
Apparently, in the citrate-bound state, the accessibility of Cys-
398 in the SSSCS mutant for MTSET was only marginally
affected in either orientation of the transporter. Similarly, only
small effects were observed on the accessibility of Cys-414 in
the SSSSC mutant. In RSO membranes, no significant effect on
the residual activity in the presence of citrate was observed,
both against NEM and against MTSET (Table I), whereas in
ISO membranes the protection was minimal (Table I and Fig.
6B, lanes 2, 5, and 6). Some protection against both NEM and
MTSET labeling was observed at 50 mM citrate and not at 5 mM
citrate, as observed for Cys-398 mutant (Fig. 4B).
Accessibility of Cys-398 and Cys-414 in the Na-bound State
of the Transporter—It was demonstrated previously (27) that
FIG. 6. Effect of Na and citrate on the labeling of SSSCS (A)
and SSSSC (B) in ISO membranes with NEM and MTSET. ISO
membranes were not further treated (lanes 1) or pretreated with NEM
(left panels, lanes 2–8) and MTSET (right panels, lanes 2–8) in the
presence of the indicated concentrations of Na and citrate. The condi-
tions of the treatment were 2 mM NEM for 20 min and 2 mM MTSET for
5 min (A) and 0.5 mM NEM and 0.5 mM MTSET for 1 min (B). After the
treatment, the mutants were purified and treated with 0.1 mM FM for
5 min. The top rows (FM) show the fluorescence image of the gel, and
the bottom rows show the gel after Coomassie Brilliant Blue (CBB)
staining. Shown on the left is the 37-kDa marker.
FIG. 5. Protection by citrate of the SSSCS mutant against NEM inactivation. Residual activity after treatment of RSO membranes (A)
and residual free thiols after treatment of ISO membranes (B) containing the SSSCS mutant with 2 mM NEM for 20 min in the presence of the
indicated concentrations of citrate. Residual activity and residual free thiols were expressed as the percentage of the activity and free thiols of
untreated membranes. The bars in B represent average and standard deviation obtained from two or three independent measurements. A typical
experiment is shown in Fig. 6A, left panel, lanes 1 and 5–7.
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the presence of Na ions protects the wild type CitS protein in
RSO membranes against inactivation by NEM. Similarly, mu-
tants SSSCS and SSSSC in RSO membranes were essentially
fully protected against inactivation by both NEM and MTSET
in the Na-bound state. Under conditions where the thiol re-
agents inactivated the mutant transporters to maximal levels
(10–20% residual activity) in Na-free buffers, the residual
activity was over 80% in the presence of saturating concentra-
tions of Na (Fig. 7A). In agreement with the lower affinity for
Na (Fig. 2), a higher concentration was needed to obtain
maximal protection of the SSSSC mutant than observed for the
SSSCS mutant (70 and 500 mM, respectively). In the presence
of Na concentrations of up to 70 mM, no protection was ob-
served in case of the SSSSC mutant (not shown). In conclusion,
in RSO membranes, the presence of sodium ions clearly pro-
tects both single Cys mutants against reacting with both the
membrane-permeable and -impermeable cysteine reagents.
In ISO membranes, the presence of 3 mM Na did not affect
the labeling of mutant SSSCS with NEM, but increasing the
concentration up to 100 mM essentially completely prevented
labeling (Fig. 6A, lanes 3 and 4). Quantification of the fluores-
cence revealed over 90% residual free thiols following the latter
condition (Fig. 7B) which corresponds to a similar level of
protection as observed in RSO membranes. With MTSET as the
modifying reagent, results were similar, but the maximal level
of protection was significantly lower (50%) than observed in
the RSO membranes (Fig. 6A lanes 3 and 4). Cys-414 in mutant
SSSSC was significantly less well protected by Na against
both reagents in ISO membranes than in RSO membranes. At
500 mM Na, the residual free thiols amounted up to 55%
after NEM treatment, whereas hardly any effect could be ob-
served after MTSET treatment (Fig. 6B, lanes 1, 3, and 4, and
Fig. 7B).
Accessibility of Cys-398 and Cys-414 in Fully Loaded State of
the Transporter—RSO membranes containing the SSSCS mu-
tant were treated with 2 mM NEM for 20 min in the presence of
3 mM Na, which is too low to affect significantly the inactiva-
tion rate. The residual activity was 28% (Table II). In parallel,
the membranes were treated the same way in the presence of
50 mM citrate instead of 3 mM Na. This concentration of
citrate results in the maximal protection by substrate (see Fig.
5A), and the residual activity in this particular experiment was
38%. Surprisingly, upon treatment with NEM in the presence
of both 3 mM Na and 50 mM citrate, which brings the trans-
porter in the translocation competent state, the transporter
was essentially completely protected against inactivation un-
der the conditions of the treatment (Table II). Apparently,
when the transporter is in the fully loaded state, Cys-398 is
much less accessible from either side of the membrane by
membrane-permeable NEM. By using a slightly different set of
concentrations, the same effect was observed for the SSSSC
mutant and with MTSET as the thiol reagent (Table II).
In ISO membranes, a concentration of 3 mM Na or 5 mM
citrate hardly affected the labeling of Cys-398 in mutant
SSSCS by NEM. However, the combination of the two resulted
in almost complete protection (compare lanes 3, 6, and 8 in Fig.
6A). Similarly, 100 mM Na and 50 mM citrate protected Cys-
TABLE I
Effect of citrate on the reaction of single Cys mutants SSSCS and
SSSSC with NEM and MTSET in RSO and ISO membranes
RSO and ISO membranes were treated with 2 mM NEM for 20 min or
2 mM MTSET for 5 min (SSSCS) and with 0.5 mM NEM and 0.5 mM
MTSET for 1 min (SSSSC). The indicated values give the residual
uptake activity in RSO membranes or residual free thiols in ISO mem-
branes as the percentage of an untreated sample. The average and
standard deviations of 2–3 independent measurements are reported.
SSSCS, citrate SSSSC, citrate
0 50 0 50
mM mM
NEM
RSO 14  2 38  3 18  2 28  4
ISO 18  3 80  4 10  3 22  2
MTSET
RSO 21  3 36  5 35  5 40  5
ISO 13  3 28  4 10  4 18  4
FIG. 7. Effect of Na on the reaction of the cysteine mutants
with NEM and MTSET. RSO (A) and ISO (B) membranes were
treated with 2 mM NEM for 20 min or 2 mM MTSET for 5 min (SSSCS),
and with 0.5 mM NEM and 0.5 mM MTSET for 1 min (SSSSC) in the
absence (white bars) or presence (gray bars) of 100 (SSSCS) or 500 mM
(SSSSC) Na. Residual activity and residual free thiols were shown as
the percentage of an untreated sample. The bars represent average and
standard deviation obtained from 2 to 3 independent measurements.
TABLE II
Effect of citrate and sodium on the inactivation of mutants SSSCS
and SSSSC with NEM and MTSET in RSO membrane vesicles
RSO membranes were treated with 2 mM NEM for 20 min or 2 mM
MTSET for 5 min (SSSCS) and with 0.5 mM NEM and 0.5 mM MTSET
for 1 min (SSSSC). The indicated values give the residual uptake
activity in RSO membranes as the percentage of an untreated sample.
The average and standard deviations of 2–3 independent measure-
ments are reported.
Mutant Reagent Addition Residual activity
%
SSSCS NEM 3 mM Na 28  5
50 mM citrate 38  3
Both 92  3
MTSET 3 mM Na 21  3
50 mM citrate 36  5
Both 88  4
SSSSC NEM 70 mM Na 38  3
50 mM citrate 28  4
Both 82  4
MTSET 70 mM Na 31  3
50 mM citrate 40  5
Both 78  5
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414 in the SSSSC mutant much better in combination than
separately, even though the protection was not complete (com-
pare lanes 3, 6, and 7 in Fig. 6B). In summary, in the fully
loaded state Cys-398 and Cys-414 appear to be the least acces-
sible from either side of the membrane.
DISCUSSION
In this study, we investigated the accessibility of residues
Cys-398 and Cys-414 in region Xa of the Na citrate trans-
porter CitS of K. pneumoniae in different catalytic states of the
transporter. Accessibility was studied in single Cys mutants in
which the other four endogenous cysteine residues were mu-
tated to Ser (SSSCS and SSSSC). Both single Cys mutants
were active in citrate transport but the mutant SSSSC had a
10-fold lower apparent affinity for Na ions (Fig. 2). The low-
ered affinity was observed in mutants SSSSC and SSSSS but
not in mutants SSSCC and SSSCS, which identifies C398S as
the responsible mutation. In all mutants tested, the lack of
uptake in the absence of Na and the sigmoidal increase of the
rate of uptake with increasing Na concentration was retained.
Therefore, the mechanism of citrate translocation is the same
for the mutants and wild type CitS; transport of citrate is
strictly coupled to translocation of two Na. Mutation C398S
that results in reduced affinity for Na is the first mutation in
CitS or any other member of the 2HCT family that affects the
interaction of the transporter with the co-ion. The residue
corresponding to Arg-428 in region Xa of CitS is known to
interact with the substrate (11, 31).
Previous studies of the SSSCC mutant of CitS and cysteine
mutants of the homologous transporter CimH of Bacillus sub-
tilis showed, surprisingly, that residues in region Xa were
accessible for membrane-impermeable MTS derivatives when
presented at the periplasmic side of the membrane (11, 27). The
MTS derivatives are similar in size to citrate (32), and it was
suggested that access from the periplasmic side of the mem-
brane might follow (part of) the substrate translocation path-
way (also see Ref. 33). Access of residues in a cytoplasmic loop
from the periplasm was explained by part of the loop folding
back into the translocation pore (a pore-loop structure) or by a
water-filled pore, which would extend all the way to the mem-
brane/cytoplasm interface where the cytoplasmic loop would
form the base of the pore. The present study shows that both
cysteine residues in region Xa of CitS that are 16 positions
apart in the primary structure are accessible for MTSET from
the periplasmic side of the membrane. Moreover, binding of
citrate to the outwardly exposed binding site affected the reac-
tivity of the two residues with MTSET only marginally (Cys-
398) or not significantly (Cys-414) suggesting that the accessi-
bility was not seriously restricted (Table I). Although only a
three-dimensional structure at atomic resolution will provide
the final answer, we feel that these characteristics are more in
line with a pore-loop model as detailed at the end of the “Dis-
cussion” than with a water-filled pore model. Most important,
both residues were equally well accessible from the cytoplasmic
side of the membrane. Access of the same site in a transporter
from both sides of the membrane is well explained by the
alternating access model of the translocation mechanism. Res-
idues that are part of the translocation site are accessible from
the two faces of the membrane under conditions when the
transporter can freely reorient the binding sites. Accessibility
from both sides corresponds to accessibility in two different
states of the protein. Access of residues in a cytoplasmic loop
from both sides of the membrane was reported before for the
glutamate transporters GltT of Bacillus stearothermophilus
and GLT-1 from the central nervous system (17, 34) and the
melibiose transporter MelB of E. coli (15). In the case of GLT-1,
additional evidence was presented that part of the cytoplasmic
loop would form a pore-loop structure (35).
In a previous paper (27), we erroneously concluded that no
binding of citrate to CitS occurs in the absence of Na. Binding
of substrate and co-ion would be ordered: first Na and then
citrate. The conclusion was based on the lack of protection of
wild type CitS against inactivation by NEM in the presence of
citrate, whereas full protection was observed in the presence of
Na. The option that citrate might bind without protecting the
protein from alkylation was considered unlikely. Here we show
that citrate does bind to the transporter in the absence of Na.
The reactivity of Cys-398 in the SSSCS mutant was reduced
upon citrate binding, especially in the inwardly oriented con-
formation of the transporter (Fig. 5B). The sensitivity of the
wild type protein in the citrate-bound state is due to the high
reactivity of Cys-414. In both orientations of the binding sites,
the binding of citrate hardly changed the accessibility of Cys-
414 either to NEM or MTSET (Table I).
In the alternating access model, the states with the inwardly
and outwardly oriented binding sites represent the two major
conformations of the transporter. The experiments revealed
different properties of the two conformations of CitS. The ac-
cessibility of Cys-398 and Cys-414 was not very different in the
outwardly oriented free or citrate-bound states (Fig. 4A and
Table I). In contrast, in the Na-bound outwardly oriented
state both residues were essentially completely protected
against reaction under conditions where the free transporter
was fully inactivated (Fig. 7A), suggesting a significant and
global change in conformation upon Na binding. At the other
side of the membrane, the accessibilities of Cys-398 and Cys-
414 seem to be more dependent on their local environment.
Citrate binding resulted in significant protection of Cys-398
against NEM treatment (Fig. 4B) but not against MTSET,
whereas little effect was observed in the case of Cys-414
against both reagents (Table I). Similarly, Na binding
strongly protected Cys-398 against NEM but less so against
MTSET, whereas Cys-414 was moderately protected against
NEM and not against MTSET (Fig. 7B). The highly protected
state of Cys-398 and Cys-414 when both citrate and Na were
present (Table II) suggests a conformation different from the
citrate-bound and Na-bound states. Possibly, substrate and
co-ions and residues near the binding sites like Cys-398 and
Cys-414 are packed in a conformation that is close to the
transition state of translocation.
The concentration of citrate necessary to promote the protec-
tive effect against NEM was 1 order of magnitude lower at the
FIG. 8. Model of the translocation site of CitS. Shown are con-
formational changes in the part of the protein around region Xa located
between transmembrane segments X and XI (represented as boxes)
upon citrate binding. Region Xa folds back in between the two segments
as a pore-loop structure. Cys-398 and Cys-414 were indicated as gray
circles. Citrate (represented as an oval) binds at the membrane/cyto-
plasm interface. See text for further explanation.
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periplasmic side of the membrane than at the cytoplasmic side
of the membrane (Fig. 4). Under the assumption that the re-
activity of the cysteine residue is similar in the two conforma-
tions of the protein, this suggests different affinities of the
inward and outward facing conformations of CitS for citrate. A
lower affinity for citrate at the cytoplasmic side of the mem
brane makes sense when the physiological function of CitS is
considered. The transporter picks up low concentrations of
citrate from the medium that upon translocation are released
into the cytoplasm.
Two structural features are essential in the model that we
propose for the translocation site of CitS (Fig. 8). (i) The Xa
region of the C-terminal cytoplasmic loop folds back inbetween
the transmembrane segments to form a pore-loop structure. (ii)
The citrate-binding site is located at the membrane/cytoplasm
interface. The latter follows from the position of Arg-428 that is
believed to be one of the residues to interact with the substrate
(11, 31) and is different from the situation in the LacY and
GlpT structures where the substrates bind halfway up the
membrane (12, 13). Important consequences of this position of
the substrate-binding site may be as follows: (i) the pore is
wider in the outward facing conformation than in the case of
LacY and GlpT, and (ii) isomerization from the outward to the
inward facing conformation may pull apart the sites on the
protein that coordinate the substrate molecule, thereby dis-
rupting the binding site. The latter mechanism would result in
significant different affinities of the two states for citrate. In
the model, the pore-loop containing Cys-398 and Cys-414 pro-
trudes into the pore beyond the citrate-binding site. In the
outward facing conformation, the two residues are accessible
for NEM and MTSET, which are small enough to enter the pore
(Fig. 8, state a). The relative position of the binding site and the
pore-loop explains the lack of effect of bound citrate on the
accessibility of Cys-398 and Cys-414; citrate binds “below” the
two residues, which renders them accessible from the
periplasm (Fig. 8, state b). Binding of Na may result in partial
closure of the pore, making it too narrow for the thiol reagents
to enter. In the inward facing orientation, the pore is wide
enough to make the residues accessible even for AmdiS (Fig. 8,
state c). Citrate binds to the remaining interaction sites of the
disrupted binding site at one side of the pore leaving enough
space for MTSET to reach the two cysteine residues (Fig. 8,
state d). Cys-398 may be closest to (part of) the citrate-binding
site because it senses the presence of citrate best from both
sides of the membrane. Finally, the fully loaded state is formed
by closure of the pore at both sides of the membrane leaving the
two cysteine residues essentially inaccessible from the water
phases at both sides of the membrane. The model predicts that
a systematic scan of the accessibility of all positions in region
Xa should reveal those sites that form the citrate-binding site
in both orientations of the transporter and the part of the loop
that forms the pore-loop structure. Such experiments are now
in progress.
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